Boston Scientific Corporation vs Macy's Inc — how do they compare? Boston Scientific Corporation trades at $51.1 (market cap $74.19B), while Macy's Inc trades at $24.53 (market cap $6.45B). The key difference: Boston Scientific Corporation is far larger — about 11.5× Macy's Inc's market cap, and Macy's Inc pays a 3.12% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | M | |
|---|---|---|
Market Cap | $74.19B | $6.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $26.21 |
52-Week Low | $42.63 | $12.73 |
Enterprise Value | $86.27B | $10.26B |
Dividend Yield | — | 3.12% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →